Smooth Muscle Cell Dynamics in Vascular Injury

Vascular injury, whether arising from atherosclerotic plaque rupture, angioplasty or bypass grafting, initiates a complex cellular response dominated by vascular smooth muscle cells (SMCs). In healthy vessels, SMCs maintain a differentiated, contractile phenotype that ensures vessel tone and blood flow regulation. Following injury, these cells undergo phenotypic modulation, adopting a synthetic state characterised by enhanced proliferation, migration and extracellular matrix (ECM) production. This shift underlies neointimal hyperplasia, a key driver of restenosis and vessel occlusion. Central to this process are growth factors and cytokines—most notably transforming growth factor-β (TGFβ), platelet-derived growth factor (PDGF) and fibroblast growth factors (FGFs)—which orchestrate intracellular signalling cascades that govern gene expression, cytoskeletal reorganisation and matrix remodelling. The balance between ECM synthesis and degradation, mediated by matrix metalloproteinases and their inhibitors, further shapes vessel architecture and long-term outcomes. Insights into SMC dynamics have global implications, informing the design of stents, pharmacological agents and gene-delivery systems aimed at limiting hyperplasia while preserving vessel integrity. By elucidating the interplay of signalling networks, phenotypic plasticity and mechanical cues, researchers are advancing targeted therapies to prevent intimal thickening and improve cardiovascular interventions worldwide.

Research from Nature Portfolio

Recent studies have clarified the molecular cross-talk that dictates SMC phenotype switching. One approach has shown that activation of FGF signalling inhibits TGFβ pathways in SMCs, triggering a transition from contractile to proliferative phenotype. Genetic deletion of the adaptor protein FRS2α in SMCs markedly reduced neointima formation and vascular remodelling in a murine injury model, highlighting FGF–TGFβ antagonism as a master regulator of pathological proliferation. A complementary investigation explored the role of TGFβ1 in recruiting mesenchymal stem cells (MSCs) after arterial balloon injury. Here, matrix metalloproteinase-14 (MMP-14) was found to liberate latent TGFβ1, promoting MSC homing and differentiation into smooth muscle-like cells within the neointima. Modulating TGFβ1/Smad signalling or MMP-14 activity significantly altered intimal thickness, underlining the potential of targeting cytokine activation and stem cell recruitment to control arterial repair.

Smooth Muscle Cell Dynamics in Vascular Injury publication trend

The graph below shows the total number of articles in smooth muscle cell dynamics in vascular injury across all publications each year (not limited to Nature Index journals).

Technical terms

Smooth muscle cell (SMC): A specialised cell type in blood vessel walls that can contract or switch to a proliferative state during injury.

Phenotypic modulation: The reversible transition of SMCs from a contractile to a synthetic, proliferative state.

Intimal hyperplasia: Thickening of the vessel’s innermost layer due to SMC proliferation and ECM deposition.

Extracellular matrix (ECM): A network of proteins and polysaccharides secreted by SMCs that provides structural support and regulates cell behaviour.

Neointima: The new tissue layer formed on the luminal side of an injured vessel, primarily composed of modulated SMCs and ECM.

References

1. TGFβ, smooth muscle cells and coronary artery disease: a review. Cellular Signalling (2018).
2. Smooth muscle FGF/TGFβ cross talk regulates atherosclerosis progression. EMBO Molecular Medicine (2016).
3. Fibroblast growth factor (FGF) signaling regulates transforming growth factor beta (TGFβ)-dependent smooth muscle cell phenotype modulation. Scientific Reports (2016).
4. Effect of TGF-β1 on the Migration and Recruitment of Mesenchymal Stem Cells after Vascular Balloon Injury: Involvement of Matrix Metalloproteinase-14. Scientific Reports (2016).
5. PEGylated Polyethylenimine Derivative‐Mediated Local Delivery of the shSmad3 Inhibits Intimal Thickening after Vascular Injury. BioMed Research International (2019).